Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-38,577.33
% of Total Estimate Gain
-27.43%

Amplify Treatments, Testing and Advancements ETF's Altimmune Inc Holding Summary

As of 2024-06-30, Amplify Treatments, Testing and Advancements ETF held - shares of Altimmune Inc(ALT), totaling N/A. This investment constitutes 0% of their stock portfolio, and Amplify Treatments, Testing and Advancements ETF now holds 0% of the outstanding Altimmune Inc(ALT) stock.

The initial trade took place in 2024Q1. In addition, there have been 1 sales at an average price of $7.38 for 13,827.00 shares. Based on historical transaction data and ALT's current price of $4.08, Amplify Treatments, Testing and Advancements ETF's estimated gain on his ALT holdings is $-38,577.33, reflecting a -27.43% gain to date.

Amplify Treatments, Testing and Advancements ETF ALT ($4.08) Holding Chart

Amplify Treatments, Testing and Advancements ETF ALT ($4.08) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1